Janney Montgomery Scott’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$894K Buy
312,710
+10,100
+3% +$31K ﹤0.01% 1982
2026
Q2
$920K Buy
302,610
+130,000
+75% +$388K ﹤0.01% 1976
2026
Q1
$532K Buy
172,610
+70,000
+68% +$297K ﹤0.01% 2007
2025
Q4
$370K Buy
102,610
+44,050
+75% +$192K ﹤0.01% 2410
2025
Q3
$221K Buy
+58,560
New +$226K ﹤0.01% 2680
2024
Q4
– Sell
-22,934
Closed -$141K – 2686
2024
Q3
$141K Buy
22,934
+3,454
+18% +$23.4K ﹤0.01% 2555
2024
Q2
$130K Buy
+19,480
New +$144K ﹤0.01% 2505

Other funds holding ALT

Janney Montgomery Scott's ALT Position: Q3 2026 in Review

Janney Montgomery Scott increased its Altimmune (ALT) stake by 3.3% in Q3 2026, buying an estimated $31K and bringing the position to 312,710 shares worth $894K. The position accounts for ﹤0.01% of the portfolio, ranked #1982.

Janney Montgomery Scott first reported a position in ALT in Q2 2024 and has held it in 7 quarters since. The position peaked at $920K in Q2 2026. 191 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • Janney Montgomery Scott held 312,710 shares of Altimmune worth $894K as of Q3 2026.
  • Janney Montgomery Scott bought 10,100 Altimmune shares in Q3 2026, an estimated $31K.
  • Altimmune made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q3 2026, its #1982 holding.
  • Janney Montgomery Scott first reported a position in Altimmune in Q2 2024 and has held it in 7 quarters since.
  • Janney Montgomery Scott's Altimmune position peaked at $920K in Q2 2026.
  • 191 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on Janney Montgomery Scott's 13F filing for Q3 2026, filed 12 Nov 2026.